Asahi Intecc has resolved to add Mr. Masahiko Miyata as Chairman of the Board of Directors, effective July 1, 2026. Mr. Miyata will leverage his extensive management experience and network within the medical device industry to support sustainable growth and strengthen corporate governance.<\/p>\n","protected":false},"comment_status":"open","ping_status":"closed","template":"","meta":{"Ticker":"","DATE":"","longName":"","company_name_ja":"","fullTimeEmployees":0,"address":"","phone":"","website":"","industry":"","sector":"","regularMarketPrice":0,"financialCurrency":"","marketCap":0,"fiftyTwoWeekLow":0,"fiftyTwoWeekHigh":0,"epsTrailingTwelveMonths":0,"epsForward":0,"bookValue":0,"totalRevenue":0,"OperatingIncome":0,"operatingMargins":0,"NetIncome":0,"profitMargins":0,"ebitda":0,"trailingPE":0,"forwardPE":0,"priceToBook":0,"returnOnEquity":0,"recommendationMean":0,"recommendationKey":"","targetMeanPrice":0,"numberOfAnalystOpinions":0,"analyst_earnings_data":"","dividendRate":0,"dividendYield":0,"payoutRatio":0,"totalEsg":0,"environmentScore":0,"socialScore":0,"governanceScore":0,"title":"","providerPublishTime":"","link":"","longBusinessSummary":"","longBusinessSummary_ja":"","quarterly_revenue":0,"quarterly_net_income":0,"quarterly_operating_profit":0,"enterprise_value":0,"company_officer_1_name":"","company_officer_1_title":"","company_officer_2_name":"","company_officer_2_title":"","company_officer_3_name":"","company_officer_3_title":"","company_officer_4_name":"","company_officer_4_title":"","company_officer_5_name":"","company_officer_5_title":"","company_officers_update_time":"","get_dividend_history_year1":0,"get_dividend_history_year2":0,"get_dividend_history_year3":0,"get_dividend_history_year4":0,"get_dividend_history_year5":0,"get_dividend_history_year6":0,"get_dividend_history_year7":0,"get_dividend_history_year8":0,"get_dividend_history_year9":0,"get_dividend_history_year10":0,"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"jir_stock_code":"7747","jir_company_name":"Asahi Intecc Co., Ltd.","jir_importance":"\u2605\u2605\u2606\u2606\u2606","jir_publication_date":"2026-06-12","jir_source_link":"https:\/\/japanir.jp\/wp-content\/uploads\/2026\/06\/7747-20260612-01.pdf","jir_short_summary":"Asahi Intecc has resolved to add Mr. Masahiko Miyata as Chairman of the Board of Directors, effective July 1, 2026. Mr. Miyata will leverage his extensive management experience and network within the medical device industry to support sustainable growth and strengthen corporate governance.","jir_summary":"### Overview of Executive Personnel Changes\nAsahi Intecc resolved to newly appoint Mr. Masahiko Miyata as Chairman of the Board of Directors effective July 1, 2026. Mr. Miyata has held roles in corporate planning and medical business management since joining the company in 1994, possessing extensive experience and networks. This personnel change aims to recover his health and contribute to management, targeting sustainable growth and strengthened governance.\n\n### Future Outlook and Corporate Strategy\nWith Mr. Miyata's appointment, Asahi Intecc will utilize its trustworthiness and network in the medical device industry to promote global expansion and new business development. Strengthening the management team aims to achieve sustainable growth and enhanced competitiveness. Details of financial forecasts and strategies are expected to be announced in the future.","jir_financial_highlights":"","jir_category":"","jir_hashtags":"#AsahiIntecc, #ExecutivePersonnelChanges, #JapaneseStocks","jir_key_figures":"Scheduled date of appointment as Chairman: July 1, 2026\nNumber of shares owned by Mr. Masahiko Miyata: 5,822,500 shares\nCareer of the scheduled appointee: Joined in 1994, held positions including Director and Executive Director, with a network in the medical device industry","jir_meta_title":"\u3010Asahi Intecc\u3011Executive Personnel Changes | Appointment Effective July 1, 2026","jir_meta_description":"Asahi Intecc resolved to newly appoint Mr. Masahiko Miyata as Chairman of the Board of Directors, effective July 1, 2026. Leveraging his extensive experience and network, the company aims for sustainable growth.","jir_og_title":"\u3010Asahi Intecc\u3011Executive Personnel Changes | Appointment Effective July 1, 2026","jir_og_description":"Asahi Intecc announces senior management personnel changes. Leveraging extensive experience and networks, the company promotes sustainable growth and strengthens governance.","jir_og_image_url":"\/assets\/og\/company-general_ir.jpg","jir_chart_data_collection":"[]","ir_related_company":7656,"ir_release_date":"","ir_type":"","ir_is_new":false,"ir_document_url":"","jir_ir_type":"executive_change","footnotes":""},"sector":[],"importance":[],"class_list":["post-63520","ir_release","type-ir_release","status-publish","hentry"],"yoast_head":"\n